OR7E106P

Across TCGA pan-cancer cohorts, OR7E106P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR7E106P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR7E106P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E106P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

ACC, SKCM, and UCS are the cancer types where OR7E106P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.047	0.675	<.001	81	view →
SKCM	OS	Tertile	II,III,IV	0.467	0.770	<.001	72	view →
UCS	OS	Tertile	III,IV	0.097	0.628	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
HNSC	DFS	Tertile	II,III,IV	0.705	0.575	.012	22	view →
LUSC	DFS	Tertile	II,III,IV	0.583	0.315	.022	18	view →
PCPG	DFS	Tertile	All	0.141	0.799	<.001	18	view →
THCA	DFS	Tertile	III,IV	0.346	0.774	.001	15	view →
STAD	OS	Quartile	III,IV	0.483	0.686	.022	14	view →
COAD	DFS	Tertile	III,IV	0.953	0.646	.025	6	view →
ESCA	OS	Tertile	IV	0.743	0.339	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR7E106P–ACC (DFS)

Open the ACC breakdown →